PGE2は,腫瘍に浸透する幹細胞のようなCD8+T細胞のエフェクター拡大を制限する
Sebastian B Lacher1, Janina Dörr2, Gustavo P de Almeida3
1Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Nature
|April 24, 2024
まとめ
腫瘍に由来する前列腺素E2 (PGE2) は,がん特異のTCF1+ CD8+ T細胞の拡大と分化を阻害する. PGE2シグナル伝達を阻害すると,T細胞の機能が回復し,腫瘍の除去が促進され,新しいがん免疫療法標的となる.
科学分野:
- 免疫学
- 癌 生物学
- 分子医学
背景:
- 癌に特異的なTCF1+幹細胞のようなCD8+T細胞は,抗癌免疫に不可欠である.
- この免疫反応はしばしば腫瘍内で機能不全し,免疫療法の有効性を制限する.
- TCF1+ CD8+ T細胞の抗癌免疫を制限するメカニズムは完全に理解されていません.
研究 の 目的:
- TCF1+ CD8+ T細胞の抗がん免疫を制限するメカニズムを調査する.
- T細胞媒介による抗がん反応の強化のための分子標的を特定する.
主な方法:
- 腫瘍内におけるTCF1+ CD8+ T細胞機能を制限する腫瘍由来プロスタグランジンE2 (PGE2) の役割が示された.
- CD8+ T細胞のEP2/EP4信号を消去するためにマウスモデルを使用した.
- PGE2がインタールイキン-2 (IL-2) 信号伝達経路に与える影響を研究した.
主要な成果:
- 腫瘍に由来するPGE2は,腫瘍の微小環境内のTCF1+ CD8+ T細胞の拡張とエフェクター分化を阻害する.
- PGE2はEP2/EP4受容体の信号伝達を通じて,腫瘍内T細胞の反応を制限する.
- EP2/EP4信号の消去はT細胞機能を回復し,マウスモデルで腫瘍の除去につながった.
- TCF1+ TILsのPGE2媒介阻害はIL-2シグナル伝達抑制と関連しています.
結論:
- 腫瘍由来PGE2は,TCF1+ CD8+ T細胞の反応を低下させることで,抗がんT細胞の免疫を抑制する鍵となる.
- PGE2- EP2/ EP4軸は,抗がんT細胞におけるIL-2応答性を回復させるための新しい治療目標を表しています.
- この軸をターゲットにすることで 癌の免疫制御と免疫療法の成果を 改善する見込みがあります
関連する概念動画
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


